Surgical treatment of secondary postuveal glaucoma by microinvasive non-penetrating deep sclerectomy with Healaflow implant injection: clinical case
The study aim was to evaluate the effectiveness of treatment of postveal uncompensated glaucoma in a patient with chronic infectious uveitis by microinvasive non-penetrating deep sclerectomy using drainage implant Healaflow. Material and methods. In a patient with the history of chronic uveitis, for the purpose of surgical treatment of secondary uncompensated post-uveal glaucoma, a microinvasive non-penetrating deep sclerectomy with the introduction of Healaflow has been performed in order to stabilize intraocular pressure, visual acuity and visual field. Healaflow was used to prevent proliferation and scarring in the early postoperative period. Results. At the follow-up period of 6 months after the operation, the drainage outflow tracts were preserved; intraocular pressure was stabilized. Conclusions. Microinvasive non-penetrating sclerectomy with Healaflow injection is the safe and effective method of surgical treatment of patients with postveal uncompensated glaucoma. The use of Healaflow is an effective method for preventing scarring of formed drainage outflow tracts.